| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS30071911 | HIV | ENSG00000136807.14 | protein_coding | CDK9 | No | No | 1025 | P50750 |
| TVIS30071912 | HIV | ENSG00000136807.14 | protein_coding | CDK9 | No | No | 1025 | P50750 |
| TVIS44031380 | HTLV-1 | ENSG00000136807.14 | protein_coding | CDK9 | No | No | 1025 | P50750 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | CDK9 |
|---|---|
| DrugBank ID | DB06195 |
| Drug Name | Seliciclib |
| Target ID | BE0002207 |
| UniProt ID | P50750 |
| Regulation Type | |
| PubMed IDs | 17108108 |
| Citations | Iurisci I, Filipski E, Reinhardt J, Bach S, Gianella-Borradori A, Iacobelli S, Meijer L, Levi F: Improved tumor control through circadian clock induction by Seliciclib, a cyclin-dependent kinase inhibitor. Cancer Res. 2006 Nov 15;66(22):10720-8. |
| Groups | Investigational |
| Direct Classification | 6-alkylaminopurines |
| SMILES | CC[C@H](CO)NC1=NC(NCC2=CC=CC=C2)=C2N=CN(C(C)C)C2=N1 |
| Pathways | |
| PharmGKB | |
| ChEMBL | CHEMBL14762 |
